Brain edema and portal-systemic encephalopathy

Liver Transplantation

Volumn 6, Issue 4 SUPPL. 1, 2000, Pages

  Blei, A T ^a  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE; LACTULOSE;

ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CIRCULATION; BRAIN DISEASE; BRAIN EDEMA; CLINICAL FEATURE; CONFERENCE PAPER; DRUG EFFICACY; HEPATIC ENCEPHALOPATHY; HUMAN; PATHOPHYSIOLOGY; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL;

EID: 0033915068     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.500060505     Document Type: Conference Paper

References (51)

1. Astroglial dysfunction in hepatic encephalopathy
2. Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy
3. Pathophysiology of cerebral edema in fulminant hepatic failure
4. Intracellular pH rises and astrocytes swell after portacaval anastomosis in rats
5. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats
6. Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis
7. Neuroactire amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure
8. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration
9. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy
10. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: Implications for ammonia-induced brain edema
11. Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis
12. Cerebral oedema and increased intracranial pressure in chronic liver disease
13. Bacterial and fungal infections in 887 ALF patients [abstract]
14. Pathways and mechanisms for cytokine signaling of the central nervous system
15. Total hepatectomy and liver transplantation as two-stage procedure
16. Liver transplantation in Europe for patients with acute liver failure
17. Changes in the blood-brain barrier in hepatic coma after hepatectomy in the rat
18. Brain edema and intracranial hypertension in rats after total hepatectomy
19. Transplantation of hepatocytes for prevention of intracranial hypertension in pigs with ischemic liver failure
20. Cerebral circulation in liver failure: Ohm's law in force
21. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: A retrospective study
22. Cerebral blood flow and metabolism in fulminant liver failure
23. Liver function, cerebral blood flow autoregulation, and hepatic encephalopathy in fulminant hepatic failure
24. Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure
25. Increased cerebrovascular resistance in cirrhotic patients with ascites
26. Mild hypothermia modifies ammonia-induced brain edema in rats after portacaval anastomosis
27. Cerebral hyperemia and the development of ammonia-induced brain edema in rats after portacaval anastomosis
28. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure
29. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure
30. The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure
31. Prognostic significance of hepatic encephalopathy in patients with cirrhosis
32. Elevation of intracranial pressure following transjugular intrahepatic porto-systemic stent-shunt for variceal haemorrhage
33. Hepatic encephalopathy in chronic liver disease: A clinical manifestation of astrocyte swelling and low-grade cerebral edema? -rfsti J Hepatol
34. Embolization of portal-systemic shunts in cirrhotic patients with chronic recurrent hepatic encephalopathy
35. The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): State of the art
36. Apolipoprotein-E (ApoE) isoforms in patients with Wilson's disease [abstract]
37. Treatment of hepatic encephalopathy
38. Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of randomized controlled trial
39. Lactulose, disaccharides and colonic flora. Clinical consequences
40. ESPEN guidelines for nutrition in liver disease and transplantation
41. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: Results of a placebo-controlled, double-blind study
42. Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: Results of a placebo-controlled double-blind study
43. Short-term oral zinc supplementation does not improve chronic hepatic encephalopathy. Results of a double-blind cross-over trial
44. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis
45. Sodium benzoate in the treatment of acute hepatic encephalopathy: A double-blind randomized trial
46. Branched-chain amino acids in the management of chronic liver disease. Facts and fantasies
47. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: An Italian multicenter double-blind, placebo-controlled, crossover study
48. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy?
49. Ammonia and GABA-ergic neurotransmission: Interrelated factors in the pathogenesis of hepatic encephalopathy
50. The peripheral benzodiazepine receptor and neurosteroids in hepatic encephalopathy
51. Energy on demand